Sildenafil | Jotup

Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer

Retrieved on:

Monday, February 26, 2024

Sildenafil, Therapy, Pfizer, RSU, Marketing, Common stock, Public health, IRON, Ascending cholangitis, Lumacaftor/ivacaftor, Ipsen, Brown University, Vertex Pharmaceuticals, Patient, Pregabalin, Public, MPH, Policy, Pharmaceutical industry

WATERTOWN, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the appointment of Pamela Stephenson, MPH as the company’s Chief Commercial Officer.

Key Points:

WATERTOWN, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the appointment of Pamela Stephenson, MPH as the company’s Chief Commercial Officer.
“We are delighted to welcome an accomplished leader such as Pamela to Disc, where her breadth of commercial experience and acumen will be instrumental as the company continues to grow,” said John Quisel, J.D., Ph.D., President and Chief Executive Officer of Disc.
Most recently, she served as the Chief Commercial Officer of Albireo, which was acquired by Ipsen, spearheading the successful launch of Bylvay for a rare cholestatic liver disease.
The Inducement Award was approved by Disc’s Board of Directors (the “Board”), including a majority of the independent directors serving on the Board.

MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY

Retrieved on:

Tuesday, February 13, 2024

RDT, Entrepreneurship, Sildenafil, SF, Arginine, Oxytocin, Music

Dallas, Texas, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (Nasdaq: MGRX) (“MangoRx” or the “Company”), a men’s health & wellness company, will offer a free one-year supply of its “Mango” erectile dysfunction product to the San Francisco players and coaches to raise spirits following Sunday’s Big Game loss, ensuring they can still perform in the bedroom after losing on the field.

Key Points:

Players and coaches of the SF-based team can send redemption inquiries to [email protected] with subject line “The Big Game” for access to their one-year supply of Mango.
MangoRx’s Tadalafil and Sildenafil based Mango ED products are compounded with both Oxytocin and L-Arginine in a tasty Mango-flavored, rapid dissolve tablet (RDT).
“With a defeating loss, the disappointment can linger into the bedroom but we want to make sure San Francisco players and fans can still score after the game.
At MangoRx, we want to help take the pressure off and focus on good times ahead,” says Jacob Cohen, Co-Founder and CEO of MangoRx.

MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS

Retrieved on:

Tuesday, February 6, 2024

Life, Arginine, Erectile dysfunction, Sadness, Oxytocin, Running, Sildenafil, Marketing, Radio, Entrepreneurship, Depression, Bedroom, Stage fright, Sport, RDT, Nursing

Dallas, Texas, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (Nasdaq: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product (“GROW”) and erectile dysfunction (“ED”) drug (“Mango”), announces that regardless of who loses the Big Game this Sunday, they are prepared to offer a free one-year supply of its Mango ED products for the entire losing team, ensuring they still get sacked after the game.

Key Points:

This code will be available to fans following the results of the Big Game.
MangoRx’s signature ED product Mango (think "Man, Go) is a uniquely formulated drug which leverages the active ingredients found in either Cialis™ (Tadalafil) or Viagra™ (Sildenafil).
MangoRx’s Tadalafil and Sildenafil based Mango ED products are compounded with both Oxytocin and L-Arginine in a tasty Mango-flavored, rapid dissolve tablet (RDT).
“Just because your team doesn’t perform on the field, doesn’t mean the fans shouldn’t be able to score.

Aspargo Laboratories Inc. Announces Completion of Dosing of All Subjects in Sildenafil Oral Suspension Bioavailability Study and Initiation of Dosing in Companion Food-Effect Study

Retrieved on:

Tuesday, December 5, 2023

Male, ED, Fed, Absorption, Plasma, Sildenafil, Prevalence, Fasting, Tablet, University, Patient, Erectile dysfunction, Pharmaceutical industry

In addition, today the Company announced the initiation of dosing of 38 subjects in two cohorts in the Company’s food effect study, comparing the amount of active drug in plasma after administration of a single oral dose of Sildenafil Oral Suspension (ASP-001) under fasting and fed (following a meal) conditions.

Key Points:

In addition, today the Company announced the initiation of dosing of 38 subjects in two cohorts in the Company’s food effect study, comparing the amount of active drug in plasma after administration of a single oral dose of Sildenafil Oral Suspension (ASP-001) under fasting and fed (following a meal) conditions.
We look forward to providing top-line data from both studies in early 2024.”
Sildenafil Oral Suspension is an oral liquid suspension of sildenafil citrate administered via a metered-dose pump that dispenses 12.5 mg of sildenafil per actuation.
Aspargo uses a metered-dose container that delivers the precise amount of sildenafil citrate per actuation based on patient need.
The discreet and easy-to-carry oral formulation allows the user to customize dosing, with physician direction, and avoid pill splitting or crushing common with the traditional tablet medication.

Mangoceuticals Announces TV Air Dates for Interview Featuring CEO Jacob Cohen on Bloomberg TV and Fox Business

Retrieved on:

Friday, October 13, 2023

In the interview, Mr. Cohen begins by laying out the Company’s potent strategy for differentiating itself as a new breed of men’s health product provider.

Key Points:

In the interview, Mr. Cohen begins by laying out the Company’s potent strategy for differentiating itself as a new breed of men’s health product provider.
According to Cohen, it starts with the idea of an “Erectile Function” pill instead of an “Erectile Dysfunction” pill.
Through that idea, Cohen believes the Company is positioning itself to tap into the relatively untapped younger demographic, which is mirrored by MangoRx’s dynamic marketing strategy.
Through its network of syndication, FMW programming reaches an estimated 540 million homes across US and international markets.

UnitedHealthcare’s 2024 Medicare Advantage Plans Offer Enhancements to Benefits that Matter Most to Members

Retrieved on:

Sunday, October 1, 2023

Highlights of UnitedHealthcare’s 2024 Individual Medicare Advantage plans:

Key Points:

Highlights of UnitedHealthcare’s 2024 Individual Medicare Advantage plans:
UnitedHealthcare UCard® is the all-in-one access point for members to use their benefits and is integrated with UnitedHealthcare’s member website and mobile app.
Hearing & Vision: UnitedHealthcare standard Medicare Advantage plans cover more than 2,000 hearing aids and devices not covered by Original Medicare with new coverage for OTC devices added in 2024.
Coverage: All standard Medicare Advantage plans will offer $0 copays for: virtual visits, mammograms and colonoscopies and routine dental, vision and hearing exams.
As the only company to offer Medicare plans with the AARP name, and as the nation’s largest Medicare Advantage, D-SNP and Medicare Supplement carrier, UnitedHealthcare serves 1 in 5 Medicare beneficiaries, or over 13 million people, through a portfolio of products that include Medicare Advantage, Medicare Part D, Medicare Supplement and retiree services.iii

Aspargo Laboratories Inc. Announces Initial Dosing of All Subjects in Bioavailability Study for Sildenafil Oral Suspension

Retrieved on:

Tuesday, September 19, 2023

Sildenafil, Volunteering, University, Prevalence, Tablet, University of Florence, Absorption, Stomach, Male, Erectile dysfunction, FDA, ED, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Pharmaceutical industry

A companion food-effect study will assess the rate and extent of absorption of ASP-001 under fasted versus fed conditions.

Key Points:

A companion food-effect study will assess the rate and extent of absorption of ASP-001 under fasted versus fed conditions.
“Completion of initial dosing of all 47 subjects in this important study represents a significant milestone in our late-stage development program of Sildenafil Oral Suspension for the treatment of ED,” said Michael Demurjian, Chief Executive Officer and Chairman of Aspargo.
We look forward to completing this comparative bioavailability study and initiating our companion food-effect study shortly and sharing results from both studies later this year.”
Sildenafil Oral Suspension is an oral liquid suspension of sildenafil citrate administered via a metered-dose pump that dispenses 12.5 mg of sildenafil per actuation.
Aspargo uses a metered-dose container that delivers the precise amount of sildenafil citrate per actuation based on patient need.

Mangoceuticals Launches New Sildenafil Based Erectile Dysfunction Product with Signature Mango Flavor & Rapid Dissolve

Retrieved on:

Wednesday, August 16, 2023

Sildenafil, Arginine, Half-life, Marketing, Oxytocin, RDT, Tablet, Investment, Entrepreneurship, Erectile dysfunction, Fine chemical, Tadalafil

Interested consumers can now proceed through the Company’s telemedicine platform and select either a Sildenafil-based Mango or the Company’s original Tadalafil-based Mango ED product, which leverages the active ingredient found in Cialis™.

Key Points:

Interested consumers can now proceed through the Company’s telemedicine platform and select either a Sildenafil-based Mango or the Company’s original Tadalafil-based Mango ED product, which leverages the active ingredient found in Cialis™.
Both the Sildenafil and Tadalafil-based Mango ED products are compounded with Oxytocin and L-Arginine in a tasty Mango-flavored, rapid dissolve tablet (RDT) and individually packaged in a master pack of six tablets per package.
For example, Tadalafil has been proven to last longer than Sildenafil due to a half-life more than four times as long.
Cohen added, “Perhaps the most important point here is that we are standing on the shoulders of billions of dollars of prior marketing spend.

Avoiding the Unpleasant Side Effects of ED Drugs

Retrieved on:

Friday, July 28, 2023

NIDDK (the National Institute of Diabetes and Digestive and Kidney Diseases) puts the number at 30 million men .

Key Points:

NIDDK (the National Institute of Diabetes and Digestive and Kidney Diseases) puts the number at 30 million men .
The only problem is that often the solution proposed is to take strong ED medications.
Harvard Health reports that ED drugs can leave men with headaches, upset stomachs, rashes, dizziness, diarrhea, and even vision problems.
The plethora of side effects undoes much of the positive elements that ED drugs can provide to a man’s quality of life.

'What does journey even mean?': Emily Perkins interrogates our obsession with wellbeing

Retrieved on:

Sunday, July 16, 2023

Fantasy, Heart, Pressure, Lioness, Bloomsbury, Male, Music, Darkness, Parasitism, Christmas, The Great Gatsby, Life, Face, Friends, Eye, Silver, Shock, Woman, Toxicity, Leeching, Running, Holiday, Atalanta, Time, Love, Sleep paralysis, Abdomen, Naivety, Burns, Trauma, Family, Disk Utility, Female, Interior design, Cosmetics, Nightclub, Toy, Book, Hunting, Sildenafil

The protagonist of Emily Perkins’ Lioness, she is instantly recognisable – and her story will engage readers who like to soak up a good psychological drama.

Key Points:

The protagonist of Emily Perkins’ Lioness, she is instantly recognisable – and her story will engage readers who like to soak up a good psychological drama.
It’s the sort of store that promotes “rituals involving candles and incense […] affirmations, cleanses, arranging your desk, changing the cushion covers”.
Review: Lioness – Emily Perkins (Bloomsbury) From humble origins, she’s risen to a point where she and financier husband, property developer Trevor, have eyes on a central Sydney location.
She toasts her gratitude to Trevor at a Christmas party – to which many of their friends do not show.
And indulged, entitled Heathcote, “with his studied loucheness, as if the family money was acceptable as long as he wasted it”.

Flaccid sex and a bohemian siren

I am a little dubious about novels that open with a sex scene, flaccid as it is – but soon realised its flaccidity is the point.
Trevor is in his seventies and hides his Viagra; Therese is in her fifties and energetically manages her homewares empire.
There is something of the unreliable narrator in Therese’s naivety, which at first seems implausible.
But Claire, who lives in a downstairs apartment in their block (and tells Therese on the first day they meet of her fantasy sex dream with Trevor) offers a window into a more liberated, more bohemian, more alluring world.
While Trevor and Therese talk domestic logistics, each glued to their screens, Claire is a “conversational minefield” who is like a siren to Therese.
Therese knows only that Claire used to work on film sets, then in fundraising, and recently lost her job.

Becoming a lioness

Therese’s transition from “catalogue model blandness” to, well, a lioness, is the real page-turner.
When she speaks or even thinks honestly, from the heart, it feels like relief – for the reader as much as for Therese.
There is a lioness tattoo on the abdomen of the mother of Therese’s personal assistant, whose manifesto could be Therese’s:
I don’t care now what I say.
She writes fiercely, lets the dialogue speak for itself and sprinkles the darkness with moments of biting, laugh-out-loud humour.
Lioness may be a queasy read – but it’s an intoxicating one.